Description
Scripps MD Anderson Cancer Center Clinical Hematology and Oncology 2024
- Include: 39 videos + 1 pdf, size: 13.4 GB
- Target Audience: hematologist, oncologist, surgeon, radiation oncologist, internist
- Sample video: contact me for sample video
 Information:
Course Overview
The Scripps Clinical Hematology and Oncology conference is designed for hematologists, oncologists, surgeons, radiation oncologists, internists, and others desiring an update in these specialty areas. The primary objective of this course is to bring together clinicians and leading experts in diverse areas of hematology and oncology, affording them an intimate environment in which to discuss new clinical developments and significant advances. Our annual program is a nationally accredited continuing medical education conference and is one of the largest annual hematology/oncology meeting held in the West, among others such as ASH, ASCO and the San Antonio Breast Meeting. This conference is one of the few that combines topics in both hematology and oncology.
Educational Objectives
After attending this live activity, participants should be able to:
• Describe the clinical and molecular facets of pathogenesis, diagnostic approaches, and therapeutic modalities available for various hematologic disorders.
• Select and apply the changing approaches to hematologic malignancies, particularly as they relate to evidence-based standards of care, including innovations in diagnosis and treatment.
• Choose new therapeutic options for the treatment of several common malignancies, understanding appropriate indications and contraindications to these therapeutic approaches.
• Integrate evolving approaches to solid tumors and breast cancer from both a diagnostic, prognostic, and therapeutic perspective.
• Apply practical expertise gained from the clinical situations discussed in the panel sessions with an emphasis on data-based approaches to patients with common, but serious hematology oncology conditions.
Target Audience
• Hematologists/Oncologists
• Medical Oncologists
• Surgeons
• Radiation Oncologists
• Internists
• And others desiring an update in these specialty areas
Topics:
- brochure_hemonc24_compressed2.pdf
- BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Anthracyclines in Early Breast Cancer Do They Still Have a Role.mp4
- BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Breast Cancer in Pregnancy.mp4
- BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA CDK4 6 Inhibitor Therapy in Early-stage HR+ HER2- Breast Cancer.mp4
- BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Combination Immunotherapy in Melanoma.mp4
- BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Neuro-Oncology 2024 Update.mp4
- BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Panel Discussion Q&A 1.mp4
- BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Panel Discussion Q&A 2.mp4
- BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Sequencing Therapies in Metastatic Urothelial Carcinoma.mp4
- Concurrent Breakout Sessions Clinical Cases Breakout 1 Interesting Cases in Thrombosis.mp4
- Concurrent Breakout Sessions Clinical Cases Breakout 2 Interesting Cases in Platelet Disorders.mp4
- Concurrent Breakout Sessions Clinical Cases Breakout 3 Interesting Cases in Bleeding.mp4
- Concurrent Breakout Sessions Clinical Cases Breakout 4 Interesting Cases in Plasma Cell Dyscrasias.mp4
- GI AND GYN CANCERS GI AND GYN CANCERS Artificial Intelligence in Oncology.mp4
- GI AND GYN CANCERS GI AND GYN CANCERS Integrating Immunotherapy into the Treatment of Cervical and Endometrial Cancers.mp4
- GI AND GYN CANCERS GI AND GYN CANCERS New Approaches to Recurrent or Metastatic Ovarian Cancer.mp4
- GI AND GYN CANCERS GI AND GYN CANCERS Panel Discussion Q&A.mp4
- GI AND GYN CANCERS GI AND GYN CANCERS Perioperative Therapy of Resectable Non-small Cell Lung Cancer.mp4
- GI AND GYN CANCERS GI AND GYN CANCERS Using ctDNA to Drive Decision Making in Adjuvant Chemotherapy of Colon Cancer.mp4
- GI AND GYN CANCERS Panel Discussion Q&A.mp4
- GI AND GYN CANCERS Perioperative Therapy of Resectable Non-small Cell Lung Cancer.mp4
- MALIGNANT HEMATOLOGY Advances in Frontline Treatment of FLT3-mutated AML.mp4
- MALIGNANT HEMATOLOGY BTK Refractory CLL.mp4
- MALIGNANT HEMATOLOGY Detangling New Approaches to Hairy Cell Leukemia A Comb or a Brush.mp4
- MALIGNANT HEMATOLOGY Management of MDS AML in the Geriatric Patient.mp4
- MALIGNANT HEMATOLOGY Myeloproliferative Neoplasms 2024 Update.mp4
- MALIGNANT HEMATOLOGY NON-HODGKIN LYMPHOMAS Frontline Treatment of DLBCL.mp4
- MALIGNANT HEMATOLOGY NON-HODGKIN LYMPHOMAS Management of Indolent NHL.mp4
- MALIGNANT HEMATOLOGY NON-HODGKIN LYMPHOMAS Panel Discussion Q&A.mp4
- MALIGNANT HEMATOLOGY NON-HODGKIN LYMPHOMAS Updates in the Treatment of Relapsed DLBCL.mp4
- MALIGNANT HEMATOLOGY Panel Discussion Q&A 1.mp4
- MALIGNANT HEMATOLOGY Panel Discussion Q&A 2.mp4
- MALIGNANT HEMATOLOGY Smoldering Multiple Myeloma.mp4
- NON-MALIGNANT HEMATOLOGY Heavy Menstrual Bleeding- Workup for Bleeding Disorder and Management.mp4
- NON-MALIGNANT HEMATOLOGY Hemolytic Anemias-Autoimmune, Membrane and Enzyme Defects.mp4
- NON-MALIGNANT HEMATOLOGY Management of Autoimmune, Viral and Surgical-associated Anti-PF4 Disorders.mp4
- NON-MALIGNANT HEMATOLOGY Management of Hematologic Conditions in Athletes.mp4
- NON-MALIGNANT HEMATOLOGY Management of Simultaneous Venous and Arterial Thromboembolic Disease.mp4
- NON-MALIGNANT HEMATOLOGY Panel Discussion Q&A.mp4
- NON-MALIGNANT HEMATOLOGY Thrombosis 2024 Update.mp4